Resources
September 28, 2020
The Biosimilars Council has identified the key issues that stand in the way of patient access to biosimilar medicines.
September 21, 2020
Biosimilars are biologic medicines that are highly similar to a previously approved reference biologic currently on the market. But what does that short definition of a biosimilar actually mean?
April 6, 2020
Employers can help speed the uptake of biosimilars. ERIC has laid out innovative practices for employers that could be implemented immediately to drive down costs.
March 4, 2020
Biosimilars have the opportunity to bring significant savings to state Medicaid programs and consumers with commercial insurance according to a study released by Pacific Research Institute.
January 30, 2020
2019 was a whirlwind year for biosimilars, highlighted by a record 10 U.S. Food and Drug Administration (FDA) approvals and increased uptake and utilization rates by payers.
November 21, 2019
The Biosimilars Council just wrapped our annual GRx+Biosims Conference, discussing greater access to generic and biosimilar medicines for patients.
